-
1
-
-
56649112752
-
Ginkgo Evaluation of Memory (GEM) Study Investigators. Ginkgo biloba for prevention of dementia: A randomized controlled trial
-
DeKosky ST, Williamson JD, Fitzpatrick AL, et al; Ginkgo Evaluation of Memory (GEM) Study Investigators. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA. 2008;300(19):2253-2262.
-
(2008)
JAMA
, vol.300
, Issue.19
, pp. 2253-2262
-
-
DeKosky, S.T.1
Williamson, J.D.2
Fitzpatrick, A.L.3
-
2
-
-
0034232147
-
Ginkgo biloba extract (EGb 761) and CNS functions: Basic studies and clinical applications
-
DeFeudis FV, Drieu K. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets. 2000;1(1):25-58.
-
(2000)
Curr Drug Targets
, vol.1
, Issue.1
, pp. 25-58
-
-
DeFeudis, F.V.1
Drieu, K.2
-
3
-
-
22844449878
-
Terpene trilactones from Ginkgo biloba: From ancient times to the 21st century
-
Nakanishi K. Terpene trilactones from Ginkgo biloba: from ancient times to the 21st century. Bioorg Med Chem. 2005;13(17):4987-5000.
-
(2005)
Bioorg Med Chem
, vol.13
, Issue.17
, pp. 4987-5000
-
-
Nakanishi, K.1
-
4
-
-
28244446721
-
A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type
-
Schneider LS, DeKosky ST, Farlow MR, Tariot PN, Hoerr R, Kieser M. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Curr Alzheimer Res. 2005;2(5):541-551.
-
(2005)
Curr Alzheimer Res
, vol.2
, Issue.5
, pp. 541-551
-
-
Schneider, L.S.1
DeKosky, S.T.2
Farlow, M.R.3
Tariot, P.N.4
Hoerr, R.5
Kieser, M.6
-
5
-
-
0029989628
-
The neuroprotective properties of the Ginkgo biloba leaf: A review of the possible relationship to platelet-activating factor (PAF)
-
Smith PF, Maclennan K, Darlington CL. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol. 1996;50(3):131-139.
-
(1996)
J Ethnopharmacol
, vol.50
, Issue.3
, pp. 131-139
-
-
Smith, P.F.1
Maclennan, K.2
Darlington, C.L.3
-
6
-
-
0034121829
-
The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β-amyloid
-
Bastianetto S, Ramassamy C, Doré S, Christen Y, Poirier J, Quirion R. The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β-amyloid. Eur J Neurosci. 2000;12(6):1882-1890.
-
(2000)
Eur J Neurosci
, vol.12
, Issue.6
, pp. 1882-1890
-
-
Bastianetto, S.1
Ramassamy, C.2
Doré, S.3
Christen, Y.4
Poirier, J.5
Quirion, R.6
-
7
-
-
36148959203
-
Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide J
-
Vitolo O, Gong B, Cao Z, et al. Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide J. Neurobiol Aging. 2007.
-
(2007)
Neurobiol Aging
-
-
Vitolo, O.1
Gong, B.2
Cao, Z.3
-
8
-
-
33845613251
-
Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans
-
Wu Y, Wu Z, Butko P, et al. Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci. 2006;26(50):13102-13113.
-
(2006)
J Neurosci
, vol.26
, Issue.50
, pp. 13102-13113
-
-
Wu, Y.1
Wu, Z.2
Butko, P.3
-
9
-
-
34547824397
-
EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease
-
Tchantchou F, Xu Y, Wu Y, Christen Y, Luo Y. EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease. FASEB J. 2007;21(10):2400-2408.
-
(2007)
FASEB J
, vol.21
, Issue.10
, pp. 2400-2408
-
-
Tchantchou, F.1
Xu, Y.2
Wu, Y.3
Christen, Y.4
Luo, Y.5
-
10
-
-
0037126035
-
Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761
-
Luo Y, Smith JV, Paramasivam V, et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci U S A. 2002;99(19):12197-12202.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.19
, pp. 12197-12202
-
-
Luo, Y.1
Smith, J.V.2
Paramasivam, V.3
-
11
-
-
34547528111
-
Ginkgo biloba is not a smart drug: An updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people
-
Canter PH, Ernst E. Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Hum Psychopharmacol. 2007;22(5):265-278.
-
(2007)
Hum Psychopharmacol
, vol.22
, Issue.5
, pp. 265-278
-
-
Canter, P.H.1
Ernst, E.2
-
12
-
-
0036668032
-
A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: Neuropsychological findings
-
Mix JA, Crews WD Jr. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharmacol. 2002;17(6):267-277.
-
(2002)
Hum Psychopharmacol
, vol.17
, Issue.6
, pp. 267-277
-
-
Mix, J.A.1
Crews Jr, W.D.2
-
13
-
-
0037151567
-
Ginkgo for memory enhancement: A randomized controlled trial
-
Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA. 2002;288(7):835-840.
-
(2002)
JAMA
, vol.288
, Issue.7
, pp. 835-840
-
-
Solomon, P.R.1
Adams, F.2
Silver, A.3
Zimmer, J.4
DeVeaux, R.5
-
14
-
-
69549105254
-
-
Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2007;(2):CD003120. doi:10.1002/14651858 .CD003120.pub2.
-
Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2007;(2):CD003120. doi:10.1002/14651858 .CD003120.pub2.
-
-
-
-
15
-
-
49449087355
-
-
McCarney R, Fisher P, Iliffe S, et al. Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, doubleblind, placebo controlled trial [published online ahead of print June 9, 2008]. Int J Geriatr Psychiatry. doi:10:1002/gps.2055.
-
McCarney R, Fisher P, Iliffe S, et al. Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, doubleblind, placebo controlled trial [published online ahead of print June 9, 2008]. Int J Geriatr Psychiatry. doi:10:1002/gps.2055.
-
-
-
-
16
-
-
42149166010
-
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline
-
Dodge HH, Zitzelberger T, Oken BS, et al. A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology. 2008; 70(19 pt 2):1809-1817.
-
(2008)
Neurology
, vol.70
, Issue.19 PART 2
, pp. 1809-1817
-
-
Dodge, H.H.1
Zitzelberger, T.2
Oken, B.S.3
-
17
-
-
33646205347
-
Ginkgo Evaluation of Memory (GEM) Study: Design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia
-
DeKosky ST, Fitzpatrick A, Ives DG. Ginkgo Evaluation of Memory (GEM) Study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials. 2006;27(3):238-253.
-
(2006)
Contemp Clin Trials
, vol.27
, Issue.3
, pp. 238-253
-
-
DeKosky, S.T.1
Fitzpatrick, A.2
Ives, D.G.3
|